Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway
Molecular Carcinogenesis · 2025
DOI: 10.1002/mc.70007 ↗At a glance
Journal article in Molecular Carcinogenesis, 2025. Written by Shangwei Xu and 5 co-authors. Institution: Department of Thoracic Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai, China. Major MEDLINE topics: Adenocarcinoma of Lung, Proto-Oncogene Proteins c-akt, Lung Neoplasms, Phosphatidylinositol 3-Kinases. Cited 1 times so far (Crossref); 45 references. Funded by: This study was supported by Huadong Hospital Affiliated to Fudan University, Wu Jieping Medical Foundation and National Nature Cultivation Youth Project..
Abstract (original language)
Lung cancer is characterized by high aggressiveness and lethality, processing in‐depth molecular mechanism investigation is particularly necessary. In our study, we found that osteoglycin (OGN) deficiency is strongly associated with a poor prognosis in lung adenocarcinoma (LUAD). OGN overexpression could inhibit the proliferation, migration, and invasion of LUAD cells. Through transcriptome sequencing analysis and experimental validation, we revealed that such OGN ‐mediated tumor suppression effect was related to cell adhesion function induced by ICAM1 downregulation, along with regulation by the PI3K/AKT signaling pathway. The present study demonstrated the specific mechanism of OGN involvement in LUAD progression, providing new evidence and potential targets for research on cancer suppression in LUAD.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Thoracic Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
- Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Respiratory Medicine, Shanghai Fengxian District Central Hospital, Shanghai, China.
ORCID profiles: Shangwei Xu
Funding
- This study was supported by Huadong Hospital Affiliated to Fudan University, Wu Jieping Medical Foundation and National Nature Cultivation Youth Project.
Cite
APA
Xu, S., Chen, C., Liu, H., Jiang, S., Li, Z., & Wu, Y. (2025). Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70007
Vancouver
Xu S, Chen C, Liu H, Jiang S, Li Z, Wu Y. Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway. Molecular Carcinogenesis. 2025. doi:10.1002/mc.70007
BibTeX
@article{Xu2025,
author = {Xu, Shangwei and Chen, Chunji and Liu, Hongwei and Jiang, Shuai and Li, Zheng and Wu, Yun},
title = {Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway},
journal = {Molecular Carcinogenesis},
year = {2025},
doi = {10.1002/mc.70007}
}
EUVIMED